The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The socio-economic burden of influenza
Open accessAbstract
Influenza epidemics and pandemics have a huge impact on society and individuals. The weight and scope of the burden of influenza varies with the age and underlying health of the patient. The disease imposes a significant burden on all individuals, but hospitalization and treatment occur more frequently in high-risk patients (the elderly and those with certain underlying medical conditions); patient populations that are increasing in size. Escalating medical costs have increased the need to quantify the burden of influenza. The first step in any such analysis is to determine the incidence of the disease; with influenza, this is often under-reported, since the illness may be confused with other viral illnesses. In addition to the direct costs of medical care, the indirect costs of influenza are substantial and stem largely from absenteeism and loss of work productivity. Estimates of the cost of influenza in the USA, France and Germany have shown that indirect costs can be five– to 10–fold higher than direct costs. Other intangible costs associated with influenza include impaired performance, which can reduce reaction times, and adverse effects on the quality of life of patients and their families. The costs of interventions should, therefore, be considered in this context. The main approach to the control of influenza and its associated costs is the administration of vaccines. Although vaccines are widely effective, the greatest potential benefits are observed within high-risk groups; vaccination is therefore recommended in many countries for high-risk patients, their carers and healthcare workers. However, the shortcomings of present vaccines, which include manufacturing limitations that prevent guaranteed adequate supply of vaccine, the difficulty in matching vaccines to circulating strains and the need for administration by injection, highlight the need for complementary treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute respiratory illness in the community: frequency of illness and the agents involved
Monto, A. S., & Sullivan, K. M. (1993) · Epidemiology and Infection · doi:10.1017/s0950268800050779 · Cited by 458
(1998) · The Lancet · doi:10.1016/s0140-6736(98)10190-3 · Cited by 351
Zanamivir in the Prevention of Influenza Among Healthy Adults: A Randomized Controlled Trial
Monto, A. S., Robinson, D. P., Herlocher, M. L., Hinson, Jr., Elliott, M. J., & Crisp, A. (1999) · JAMA · doi:10.1001/jama.282.1.31 · Cited by 321
Cited by
Seasonality, Timing, and Climate Drivers of Influenza Activity Worldwide
Azziz Baumgartner, E., Dao, C. N., Nasreen, S., Bhuiyan, M. U., Mah-E-Muneer, S., Mamun, A. A., Sharker, M. A. Y., Zaman, R. U., Cheng, P.-Y., Klimov, A. I., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis467 · Cited by 306
Ferreira da Silva, M., Vaz-Moreira, I., Gonzalez-Pajuelo, M., Nunes, O. C., & Manaia, C. M. (2007) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2006.00268.x · Cited by 269
Immunogenicity and protective efficacy of influenza vaccination
Hannoun, C., Megas, F., & Piercy, J. (2004) · Virus Research · doi:10.1016/j.virusres.2004.02.025 · Cited by 260
Gentamicin resistance genes in environmental bacteria: prevalence and transfer
Heuer, H., Krögerrecklenfort, E., Wellington, E. M. H., Egan, S. A., van Elsas, J. D., van Overbeek, L. S., Collard, J., Guillaume, G., Karagouni, A. D., Nikolakopoulou, T. L., et al. (2002) · FEMS Microbiology Ecology · doi:10.1016/s0168-6496(02)00342-2 · Cited by 255
Infectious respiratory illnesses and their impact on healthcare workers: a review
Low, J., & Wilder-Smith, A. (2005) · Annals of the Academy of Medicine, Singapore · doi:10.47102/annals-acadmedsg.v34n1p105 · Cited by 46
Metadata
- Authors
- Szucs, T.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-11-01
- Volume
- 44
- Issue
- suppl_2
- Pages
- 11-15
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2162461975
- Cited by
- 166
- References
- 3
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The socio-economic burden of influenza. https://app.cochat.ai/papers/10.1093/jac/44.suppl_2.11
- The paper
- Szucs, T. (1999). The socio-economic burden of influenza. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/44.suppl_2.11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.